Nkarta (NKTX) Liabilities and Shareholders Equity (2019 - 2026)

Nkarta's quarterly Liabilities and Shareholders Equity came in at $372.1 million in Q1 2026, down 20.94% year-on-year from $470.6 million in Q1 2025, and down 7.95% quarter-over-quarter from $404.2 million in Q4 2025.

Nkarta has reported Liabilities and Shareholders Equity for 8 years, with the latest figure at $372.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 20.94% year-over-year to $372.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.7 billion (down 19.73% YoY), and the FY2025 full-year result was $404.2 million, down 19.35% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $372.1 million, down from $404.2 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $576.9 million in Q1 2024, with the low at $306.3 million in Q1 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $455.6 million, with a median of $458.2 million recorded in 2023.
  • Year-over-year, Liabilities and Shareholders Equity jumped 72.67% in 2022 and fell 20.94% in 2026.
  • Tracing NKTX's Liabilities and Shareholders Equity over 5 years: stood at $472.9 million in 2022, then declined by 19.89% to $378.9 million in 2023, then soared by 32.28% to $501.2 million in 2024, then decreased by 19.35% to $404.2 million in 2025, then dropped by 7.95% to $372.1 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $372.1 million (Q1 2026), $404.2 million (Q4 2025), and $427.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 14.93 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 37.37 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 1.73 Bn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 78.88 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 33.89 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 26.48 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 23.64 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 40.87 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 5.13 Bn
10 Nkarta 232.80 Mn 232.80 Mn - 372.07 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 372.07 Mn
Dec 31, 2025 404.21 Mn
Sep 30, 2025 427.24 Mn
Jun 30, 2025 448.31 Mn
Mar 31, 2025 470.61 Mn
Dec 31, 2024 501.20 Mn
Sep 30, 2024 532.03 Mn
Jun 30, 2024 554.09 Mn
Mar 31, 2024 576.94 Mn
Dec 31, 2023 378.89 Mn
Sep 30, 2023 405.86 Mn
Jun 30, 2023 429.04 Mn
Mar 31, 2023 458.17 Mn
Dec 31, 2022 472.94 Mn
Sep 30, 2022 503.80 Mn
Jun 30, 2022 503.64 Mn
Mar 31, 2022 306.30 Mn
Dec 31, 2021 273.90 Mn
Sep 30, 2021 292.47 Mn
Jun 30, 2021 309.11 Mn
Mar 31, 2021 325.69 Mn
Dec 31, 2020 337.65 Mn
Sep 30, 2020 352.30 Mn
Jun 30, 2020 43.62 Mn
Dec 31, 2019 48.41 Mn